CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Dr Camilla Zimmermann
William E. Rawls Prize recipient in 2010
Dr Zimmermann is interested in determining and improving the effectiveness of specialized palliative care. Her current Canadian Cancer Society grant focuses on the effectiveness of early versus routine specialized palliative team involvement in patients with metastatic cancer. Outcomes include patient quality of life, satisfaction with care, and physician-patient communication.
Dr Zimmermann is head of palliative services at the University Health Network, palliative care co-lead in the Toronto Central Regional Cancer Program, Cancer Care Ontario, and associate professor, department of medicine, University of Toronto. She is also a scientist at the Ontario Cancer Institute and has her PhD from the University of Toronto.
Dr Zimmermann has built a remarkable research program in a short period of time and her progress has been extraordinary. She has already become an internationally recognized expert in palliative care. She has published extensively in peer-reviewed journals, including an important systematic review of the effectiveness of palliative care. In this landmark paper, she has stimulated critical evaluation of the field and a rethinking of the methodology of clinical trials in palliative care.
What’s the lifetime risk of getting cancer?
The latest Canadian Cancer Statistics report shows about half of Canadians are expected to be diagnosed with cancer in their lifetime.